Bayer AG (BAYRY)
13.76
-0.37
(-2.62%)
USD |
OTCM |
Sep 18, 16:00
Bayer Price to Book Value : 1.599 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.599 |
| September 17, 2026 | 1.642 |
| September 16, 2026 | 1.632 |
| September 15, 2026 | 1.631 |
| September 14, 2026 | 1.658 |
| September 11, 2026 | 1.621 |
| September 10, 2026 | 1.635 |
| September 09, 2026 | 1.663 |
| September 08, 2026 | 1.664 |
| September 04, 2026 | 1.649 |
| September 03, 2026 | 1.667 |
| September 02, 2026 | 1.652 |
| September 01, 2026 | 1.640 |
| August 31, 2026 | 1.656 |
| August 28, 2026 | 1.629 |
| August 27, 2026 | 1.639 |
| August 26, 2026 | 1.656 |
| August 25, 2026 | 1.666 |
| August 24, 2026 | 1.640 |
| August 21, 2026 | 1.634 |
| August 20, 2026 | 1.640 |
| August 19, 2026 | 1.670 |
| August 18, 2026 | 1.640 |
| August 17, 2026 | 1.608 |
| August 14, 2026 | 1.608 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.608 |
| August 12, 2026 | 1.616 |
| August 11, 2026 | 1.658 |
| August 10, 2026 | 1.650 |
| August 07, 2026 | 1.678 |
| August 06, 2026 | 1.664 |
| August 05, 2026 | 1.654 |
| August 04, 2026 | 1.624 |
| August 03, 2026 | 1.577 |
| July 31, 2026 | 1.614 |
| July 30, 2026 | 1.623 |
| July 29, 2026 | 1.585 |
| July 28, 2026 | 1.567 |
| July 27, 2026 | 1.556 |
| July 24, 2026 | 1.526 |
| July 23, 2026 | 1.526 |
| July 22, 2026 | 1.550 |
| July 21, 2026 | 1.580 |
| July 20, 2026 | 1.560 |
| July 17, 2026 | 1.603 |
| July 16, 2026 | 1.580 |
| July 15, 2026 | 1.584 |
| July 14, 2026 | 1.623 |
| July 13, 2026 | 1.645 |
| July 10, 2026 | 1.659 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck KGaA | 1.875 |
| Breakthrough Chemistry, Inc. | 1.523 |
| Cardiac Biotech Solutions, Inc. | -- |
| Fresenius SE & Co. KGaA | 1.325 |
| Carl Zeiss Meditec AG | 3.058 |
Price to Book Value Related Metrics
| PS Ratio | 1.022 |
| Price to Free Cash Flow | 73.20 |
| Price | 13.76 |
| Earnings Yield | -3.72% |
| Market Cap | 54.07B |
| Operating PE Ratio | 7.396 |
| Normalized PE Ratio | 27.86 |